The late bird gets the worm

The cat that got the canary last week was VimRx Pharmaceuticals Inc., which has spent almost nothing for a product that others spent millions to develop. VMRX will acquire the 20 percent of the Nexell Therapeutics Inc. joint subsidiary

Read the full 397 word article

How to gain access

Continue reading with a
two-week free trial.